207_Combined course Presentations

First page Table of contents Previous page 894 Next page Last page

PFS

OS

3 years OS: 46% vs 32%

3 years OS: 38% vs 21%

p = 0.07

p = 0.01

CONCLUSION: High dose MTX-Cytarabine is the new standard chemotherapeutic approach

Ferreri AJ et al, Lancet 2009; 374

Made with